Gram-Negative Bloodstream Infection (Nov 16, 2018)

Gram-Negative Bloodstream Infection is organized by Healthcare (HC) - UK Conferences and will be held on Nov 16, 2018 at De Vere West One, London, England, United Kingdom.

Conference Description:
This conference focuses on the effective management and reduction of Gram-negative bloodstream infection in line with the National Programme ambition to halve healthcare-associated Gram-negative bloodstream infections by March 2021. The day will include an extended focus on reducing E.coli bloodstream infections.

The will be an extended focus on reducing E.coli bloodstream infections. NHS Improvement recently stated, “We have seen an increase in the number of E.coli bloodstream infections despite decreases in MRSA bloodstream infections and CDI infections”. The benefits of reducing these infections include:
• improved patient safety through reduced infection rates, mortality, length of stay and appropriate antimicrobial prescribing
• improved patient experience through the prevention of avoidable infections and reduced length of inpatient stay
• improved population health through reduced antimicrobial resistance
• potentially between £900-£2400 per patient saved for each E.coli BSI prevented (NHS Improvement).

Benefits of attending:
• Network with colleagues who are effectively working to manage and reduce Gram-negative bloodstream infection
• Understand the national context including the National Programme ambition to halve healthcare-associated Gram-negative bloodstream infections by March 2021
• Develop your skills in managing and reducing gram-negative bloodstream infection
• Learn about the benefits of reducing infections including improved patient safety and lower mortality rates
• Understand how improved patient experience through the prevention of avoidable infections can reduce length of inpatient stay
• Develop effective strategies for intervention
• Understand how you can improve surveillance
• Develop effective systems for the reporting of blood cultures
• Ensure investigation and learning from all incidents of E.coli
• Learn from established practice in the reduction of Catheter-Associated Urinary Tract Infections
• Ensure effective management of invasive devices
• Learning from PHE National Data Collection and Risk Factor Analysis of Klebsiella species and Pseudomonas aeruginosa
• Self-assess and reflect on your own practice
• Gain CPD accreditation points contributing to professional development and revalidation evidence

Additional details will be posted as soon as they are available.